A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
Clinical trial NCT07260500 · RECRUITING
Trial details
- NCT number
- NCT07260500
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2026-12-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.